Skip to main content
Clinical Trials/NCT01713062
NCT01713062Active, not recruitingNot Applicable

Randomised Prospective Multicenter Longterm-Evaluation of the Survival Rate of the Implant, Wear and Periprosthetic Osteolysis of Highly Cross-linked Polyethylene With and Without Addition of Vitamin E (UHMWPE-XE vs. UHMWPE-X)

Aesculap AG6 sites in 1 country400 target enrollmentStarted: January 1, 2012Last updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Active, not recruiting
Enrollment
400
Locations
6
Primary Endpoint
Analysis and measurement of oxidation index of the Polyethylene Inlay after Revision

Study Overview

Brief Summary

The purpose of this randomised prospective multicenter longterm study is to evaluate the survival rate of the implant, wear and periprosthetic osteolysis of highly cross-linked polyethylene with and without addition of Vitamin E (UHMWPE-XE vs. UHMWPE-X) in Total Hip Arthroplasty.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to 75 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Analysis and measurement of oxidation index of the Polyethylene Inlay after Revision

Time Frame: Oxidation index is assessed in case of loosening and revision within 15 years

The Oxidation index is measured after explantation in case of loosening of the inlay

Secondary Outcomes

  • Manifest radiological osteolyses(Measured radiologically after 1, 5, 10 and 15 years)
  • Traceable wear of polyethylene over 0.5 mm(Measured radiologically after 1, 5, 10 and 15 years)
  • Clinical Outcome(After 1, 5, 10 and 15 years)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (6)

Loading locations...

Similar Trials

Longterm-Evaluation of Vitelene® Against... | Clinical Trial